Find Academic Supervisors

• Long non-coding RNA (lncRNA) research
• Lipid Metabolism
• Adipocyte Biology
• +3 more

Alastair Kerr is a Senior Research Specialist and Group Leader at the Department of Medicine, Huddinge, Karolinska Institutet. His research focuses on elucidating how long noncoding RNAs (lncRNAs) regulate lipid metabolism and contribute to cardiometabolic disease in adipocytes. He leads the Long noncoding RNA in the adipocyte research group, which integrates human adipose tissue biopsies, population genetics, and advanced molecular tools like CRISPRi/a and his novel TROOPS method to study lncRNA functions. Education & Career PhD in Molecular Biology (University of Oxford, 2017) Postdoctoral studies at Karolinska Institutet (2017–present) Research Highlights He discovered the lncRNA ADIPINT, which modulates pyruvate carboxylase activity to regulate triglyceride synthesis. His lab investigates lncRNA roles in lipid droplet metabolism and develops methods like TROOPS for high-throughput lncRNA interactome analysis. Current work links genetic variants in lncRNAs to metabolic dysfunction. Awards & Funding Swedish Research Council grants Novo Nordisk Foundation support ERC Starting Grant (2024) Laboratory Team Jordi Mengual Martí (Research Assistant) Katharina Schormair (PhD Student) Bingran Xie (Postdoctoral Researcher) Opportunities Open positions for students and researchers; contact alastair.kerr@ki.se for inquiries.

Minh Ngoc TranView profile

Researcher

• Bioinformatics
• Health Data Science
• Cancer Cell Biology
• +5 more

Dr Minh Ngoc Tran is a Researcher at the University of New South Wales (UNSW), affiliated with the Faculty of Medicine & Health Sciences. His work focuses on bioinformatics, health data science, and artificial intelligence applied to cancer research and molecular biology. Tran specializes in spatial analysis of cancer tissues, integrating single-cell sequencing with imaging to study tumor microenvironments and immune responses. His research also explores computational frameworks for multi-omics data and epigenetic mechanisms underlying aging and disease. Key areas of interest include colorectal cancer heterogeneity, SARS-CoV-2 pathogenesis, and translational bioinformatics for precision medicine. Tran's research employs advanced techniques such as spatial transcriptomics, multiplexed imaging mass cytometry, and AI-driven diagnostic models. His work bridges computational innovations with clinical relevance, particularly in oncology and infectious diseases. Recent projects include developing robust platforms for spatial multi-omics analysis and identifying early biomarkers for severe COVID-19 outcomes. While his articles emphasize cancer biology and immunology, they also highlight contributions to virology, epigenetics, and genomic technologies. Collaboration with interdisciplinary teams at UNSW and beyond drives his efforts to translate scientific discoveries into clinical applications.

Jonathan WorboysView profile

Research Fellow

• Immunology
• Cell biology
• Proteomics
• +4 more

Jonathan Worboys is a Wellcome Trust Research Fellow at the University of Manchester, affiliated with the Lydia Becker Institute of Immunology and Inflammation and the Division of Immunology, Immunity to Infection & Respiratory Medicine. He holds a PhD in Cancer Biology (2015) from the Institute of Cancer Research (University of London) and a BSc in Biology with a Year in Europe from Imperial College London (2010). PhD: Cancer Biology, Institute of Cancer Research (2015) BSc: Biology with a Year in Europe, Imperial College London (2010) His research investigates how spatial organization of immune receptors governs their function, focusing on immune checkpoints—proteins that regulate immune responses and are critical in cancer immunotherapy. Current therapies targeting these checkpoints lack refinement, and his work aims to improve their efficacy. His recent studies explore TIGIT receptor dynamics, NLRP3 inflammasome regulation, and super-resolution microscopy applications. He received the 2024 Research Staff Excellence Award and leads an 8-year Wellcome Trust-funded project on nanoscale immune checkpoint governance. Expertise spans immunology , cell biology , super-resolution microscopy , and mass spectrometry . His work contributes to SDG-related research in health and well-being through immune signaling advancements.

• Virology
• Immunology
• Infectious Diseases
• +3 more

Professor Kirsty Short holds the NHMRC Senior Principal Research Fellow position at the School of Chemistry and Molecular Biosciences, The University of Queensland. She is affiliated with the Centre for Cardiovascular Health and Research and the Centre for Extracellular Vesicle Nanomedicine within the Faculty of Health, Medicine and Behavioural Sciences. Her research focuses on viral pathogenesis, immune responses to respiratory viruses, and the interplay between metabolic conditions (e.g., diabetes) and infectious diseases. She is actively involved in supervising PhD students and has secured significant funding for projects addressing pandemic preparedness, antiviral strategies, and post-acute sequelae of SARS-CoV-2. Dr. Short’s academic background includes a Bachelor of Arts, a Bachelor of Science (Honours), and a PhD, all from the University of Melbourne. Her work spans virology, immunology, and molecular biology, with a particular emphasis on influenza and coronaviruses. She investigates how metabolic disorders influence viral disease severity and immune responses, contributing to translational research aimed at mitigating pandemic threats. Her research highlights include studies on glycemic variability’s impact on cardiovascular outcomes in diabetes, the role of vagal sensory neurons in influenza pathogenesis, and the development of antiviral polymers. She collaborates widely, leveraging interdisciplinary approaches to address global health challenges.

• Alzheimer’s Disease
• Myelin Biology
• APOE4 Effects
• +3 more

Leyla Akay is a Researcher affiliated with the Picower Institute for Learning & Memory at Massachusetts Institute of Technology (MIT). Her work focuses on molecular mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s Disease (AD), with an emphasis on myelin biology, lipid metabolism, and APOE4 genotype effects. She employs cutting-edge techniques including single-cell transcriptomics, in vitro human cell models, and systems biology approaches to dissect disease pathways. Her research interests integrate cellular biology, genetics, and neurovascular dynamics, targeting APOE4’s role in myelination defects, cholesterol dysregulation, and vascular dysfunction in AD. Recent studies highlight novel insights into multisensory stimulation’s impact on glymphatic clearance and the role of microglial Siglec-F in neuroinflammation. Her publications span 2018-2025, emphasizing multi-region brain analysis, lipid homeostasis disruption, and in vitro BBB modeling. While no awards or grants are explicitly listed, her work aligns with Picower’s focus on translational neuroscience. She is actively involved in collaborative projects at MIT’s Picower Institute, contributing to the institute’s initiatives in neurodegenerative disease research.

Fabian J. TheisView profile

Professor

• Systems Biology
• Mathematical Modeling
• Single-Cell Analysis
• +3 more

Prof. Dr. Dr. Fabian J. Theis is a full Professor of Biomathematics at Technische Universität München (TUM) since 2013 and Director of the Institute of Computational Biology at the Helmholtz Center Munich. He leads the Theis Lab, focusing on machine learning approaches for single-cell genomics and systems biology. His academic journey includes a doctorate in biophysics (2002) and computer science (2003), followed by postdoctoral work in Regensburg, Tokyo, and Tallahassee. Research areas include mathematical modeling of biological processes, single-cell analysis, and integrating omics data into systems medicine. He has advised numerous PhD candidates and leads projects on computational health, including the Lung Cell Atlas and drug discovery. Notable awards include the Gottfried Wilhelm Leibniz Prize (2023) and ERC Advanced Grant (2022). His lab hosts over 50 researchers, including postdocs, PhD candidates, and engineers, working on topics like spatial transcriptomics and multi-modal data integration. Collaborations with global institutions drive advancements in computational biology and medical discovery.

• Atherosclerosis Research
• Macrophage Biology
• Systems Biology
• +3 more

Professor Joseph Boyle is a Professor of Chemical Systems Pathology at the National Heart and Lung Institute, Imperial College London, within the Faculty of Medicine. His research focuses on gene regulation in macrophages related to atherosclerosis, integrating systems biology, pharmacology, and clinical translation. He holds affiliations with the Immuno-Pathology Network, Vascular Science Network, and Vasculitis Centre. Trained as a histopathologist (FRCPath), he combines clinical expertise with laboratory research in vascular biology. Education: BSc (Hons) Pharmacology (University of Glasgow, 1988), MBChB (Glasgow, 1991), PhD (University of Cambridge, 1997–2001). Professional milestones include histopathology training (1992–2001) and postdoctoral fellowships at Imperial College London. Research interests emphasize protective gene regulation in macrophages, leveraging spatial transcriptomics and imaging technologies. His work spans drug development (e.g., metformin’s anti-atherosclerotic effects), enzyme-based probes (HO-1 detection), and immune responses in cardiovascular disease. Awards include the University of Glasgow Pharmacology Prize and FRCPath certification. Key contributions include identifying roles of SMARCA4, ATF1, and AMPK in macrophage function, and developing molecular imaging tools for atherosclerosis. His lab explores translational applications of these findings in diagnostics and therapeutics.

Chris HanleyView profile

Associate Professor

• Tumour Microenvironment
• Cancer-associated Fibroblasts
• Extracellular Matrix
• +3 more

Dr. Chris Hanley is an Associate Professor at the University of Southampton's Cancer Sciences Unit. He specializes in understanding how the tumour microenvironment influences cancer progression, particularly focusing on cancer-associated fibroblasts (CAFs). His research employs cutting-edge techniques such as single-cell RNA-sequencing and 3D organoid co-cultures. A key achievement includes identifying NOX4 as a therapeutic target, leading to patented NOX inhibitors (WO2019086579) with ongoing clinical trials. Education: BSc Biochemistry (Imperial College London, 2008), MRes (University of Southampton, 2011), PhD in Cancer Research (University of Southampton, 2014). Postdoctoral positions at Southampton Cancer Sciences Unit and Johns Hopkins Centre for Cell Dynamics. Teaching responsibilities include co-leading the MSc Genomics Dissertation Module and leading sessions in the MRes Quantitative Cell Biology and Protein Biology courses. Currently supervising three PhD students. Active research projects include CRUK-funded initiatives investigating CAF roles in immunotherapy resistance and lung cancer progression. Collaborations with institutions like Gilead Sciences and Rosetrees Trust highlight interdisciplinary research efforts.

• Nanoparticle
• Copolymer
• Transfection
• +5 more

Marck Norret is a Research Fellow at The University of Western Australia's School of Molecular Sciences, where he conducts interdisciplinary research at the intersection of chemistry, pharmacology, and biomedical sciences. His work contributes to several UN Sustainable Development Goals, particularly those related to health innovation and scientific advancement. Dr. Norret holds a Doctorate, Master of Science from Manchester (MSc Manc.), and PhD from Sydney (PhD Syd.). His educational background has prepared him for advanced research in molecular sciences and drug development, with an h-index of 16 and 745 citations according to Scopus metrics. His research spans multiple cutting-edge areas in molecular science, with particular expertise in nanoparticle technology, copolymer systems, transfection methods, macrocyclic chemistry, DNA interactions, methacrylate applications, cancer therapeutics, and fullerene chemistry. Dr. Norret's fingerprint analysis reveals strong contributions to pharmacology, toxicology, pharmaceutical science, biochemistry, genetics, molecular biology, and chemistry. Dr. Norret's recent publications demonstrate a clear trajectory toward biomedical applications of molecular systems, particularly in cancer therapy, drug delivery mechanisms, and molecular imaging. His work increasingly focuses on translating fundamental chemical discoveries into clinically relevant solutions, with several publications exploring tumor immunity, oligonucleotide delivery, and hydrogel-based therapeutic systems. Optimisation of Kinetic Inhibition of Methane Hydrate Re-Formation (2025) WA Facility for Drug and Biomaterials Discovery and Development (2020) Reprogramming anti-tumour therapy responses by locus selective manipulation of the epigenome in breast cancer (2020-2024) Integrated Process Intensification Facility (2008) His collaborative network extends across multiple institutions and research groups, with particular connections to researchers working on cancer immunotherapy, drug delivery systems, and molecular imaging techniques. Dr. Norret's work appears to be centered in well-equipped research facilities that support both fundamental chemical research and translational biomedical studies.

Xiao WangView profile

Associate Professor

• Molecular Biology
• Neuroscience
• Biophysics
• +6 more

Xiao Wang is the Thomas D. and Virginia Cabot Associate Professor of Chemistry at the Massachusetts Institute of Technology (MIT) and a Core Member of the Broad Institute of MIT and Harvard. His research focuses on developing chemical and biophysical tools to study molecular events in the brain, including spatial transcriptomics, in-situ sequencing, and imaging methods. The Wang Group works at the intersection of chemistry, biophysics, and genomics to map brain wiring and function at unprecedented resolution. Key research areas include spatial omics technologies for single-cell resolution, RNA modification engineering, and applications in neuroscience and therapeutics. The lab is known for pioneering methods like STARmap and ClusterMap for spatial gene expression analysis. Recent work extends to AI-driven spatial transcriptomics and optimizing mRNA translation capacity through chemical design. Publications highlight innovations in spatial multi-omics, mRNA therapeutics, and neurobiological mechanisms. The lab collaborates extensively with institutions like Harvard Medical School and the Broad Institute. Current projects emphasize scalable spatial tools and translational applications of molecular imaging. Advising and grants: Xiao Wang mentors over 20 PhD students and postdocs. Funding includes support from the Damon Runyon Foundation (Wendy Wang) and NIH grants. The lab actively recruits postdocs and students through MIT’s Chemistry and related departments. Labs/teams: The Wang Group operates at MIT and the Broad Institute, leveraging interdisciplinary approaches to address challenges in molecular neuroscience and precision medicine.

• Artificial Intelligence
• Spatial Transcriptomics
• Gene Regulatory Networks
• +7 more

Sokratia Georgaka is a Lecturer in Artificial Intelligence at the Division of Informatics, Imaging & Data Sciences. Her research focuses on spatial transcriptomics, gene regulatory networks, and predictive modeling of biological systems, particularly in liver disease and glioblastoma. She holds a PhD in Reduced Order Models for Nuclear Reactor Thermal Hydraulics from Imperial College London (2020), a Master's from the University of Birmingham (2014), and a Bachelor's from the University of Ioannina (2013). Her work contributes to UN Sustainable Development Goals related to health and innovation. Recent projects include developing computational methods for spatial transcriptomics (CellPie) and integrating multi-omic data to study liver fibrosis and glioblastoma progression. Collaborations include the Christabel Pankhurst Institute and institutions in oncology and bioinformatics. Publications emphasize applications of machine learning in medical imaging and molecular biology, with notable contributions to Science Advances , Nucleic Acids Research , and Bioinformatics .

Dharmesh D BhuvaView profile

Research Fellow

• Computational Biology
• Spatial Transcriptomics
• Systems Biology
• +3 more

Dr Dharmesh D Bhuva is an NHMRC Emerging Leadership Fellow (EL1) at the Frazer Institute, University of Queensland. His research focuses on systems biology approaches to understand gene regulation and signaling in health, disease, and development, with an emphasis on spatial transcriptomics and computational methods for molecular data analysis. He completed his PhD in Mathematics and Statistics at the University of Melbourne (2020), developing novel methods for cancer systems biology. Bhuva has secured over $3.25M in funding, including NHMRC and MRFF grants, and developed widely used bioinformatics tools (e.g., vissE, mastR) with over 160,000 downloads. Research Interests His work spans computational biology, spatial transcriptomics, and bioinformatics tool development. Key areas include: Normalization of spatial molecular datasets Gene expression analysis in cancer systems Functional enrichment visualization (vissE) Molecular signatures in SARS-CoV-2 infection Grants & Awards NHMRC Emerging Leadership Fellowship (EL1) MRFF Grant Recipient Advising & Mentorship Current PhD student supervisor; co-supervised 2 successful MSc Bioinformatics students. Delivered computational biology workshops (e.g., WEHI Masterclass 2021, University of Melbourne). Labs & Collaborations Associated with the Frazer Institute and the South Australian Immunogenomics Cancer Institute (SAiGENCI). Collaborates widely on projects involving spatial transcriptomics, cancer systems biology, and infectious disease genomics.

Andrew BakerView profile

Professor

• Marine Biology
• Coral Reef Ecology
• Climate Change Impacts
• +3 more

Andrew Baker is a Professor in the Department of Marine Biology & Ecology at the Rosenstiel School of Marine, Atmospheric, and Earth Science, University of Miami. His research focuses on coral symbiosis, climate change impacts, and coral reef resilience, particularly in the Caribbean and tropical Pacific. He explores how corals adapt to environmental stressors like warming oceans, sedimentation, and disease through symbiont dynamics, genetic diversity, and ecological interactions. Key research areas include thermal tolerance mechanisms, symbiont shuffling, coral disease ecology, and restoration strategies. His work integrates field studies, laboratory experiments, and molecular techniques to understand coral survival under climate change. Recent publications address heatwave impacts on symbiont communities, sediment effects on larval survival, and disease management in Caribbean reefs. Baker collaborates on interdisciplinary projects, such as artificial reef engineering for coastal protection and genomic approaches to enhance coral resilience. His findings contribute to conservation policies, restoration efforts, and global coral reef management strategies.

Joseph M. LunaView profile

Assistant Professor

• RNA Biology
• Molecular Virology
• Host-Pathogen Interactions
• +4 more

Joseph M. Luna, PhD is an Assistant Professor in the Department of Biochemistry at Case Western Reserve University's School of Medicine. He leads the Luna Lab, which focuses on RNA-binding proteins (RBPs) in viral infections and cellular stress responses. His work uses positive-sense RNA viruses as models to study viral replication, innate immunity, and host-pathogen interactions. Member of the Center for RNA Science and Therapeutics Member of the Cancer Genomics and Epigenomics Program at Case Comprehensive Cancer Center Director of the Advanced RNA Profiling Core PhD from The Rockefeller University (2015) Postdoctoral training at The Rockefeller University Research interests include: - Subcellular RBP:RNA interaction mapping using novel spatial CLIP techniques - Dynamics of RBPs during viral infections (HCV/SARS-CoV-2) - RBP networks in innate immunity - Development of advanced RNA-profiling methods Recent work emphasizes: - Spatial resolution of RNA interactions in viral replication organelles - CRISPR-based screening for host factors in coronavirus infections - Systems-level modeling of RBP activities Key achievements include: - Co-developed SARS-CoV-2 replicon systems enabling antiviral research - Identified miR-122 sequestration mechanisms in hepatitis C infection - Trained students from underrepresented groups in biomedical research Labs/Teams: - Advanced RNA Profiling Core facility director - Collaborations with virology, immunology, and systems biology groups

• Oncology
• Neuro-Oncology
• Head and Neck Cancer
• +6 more

Paul Clement is a Professor and Department Chair at the KU Leuven Faculty of Medicine , leading the Department of Oncology . His research spans neuro-oncology, head and neck cancer, and precision medicine, with expertise in immunotherapy, radiation therapy, and translational oncology. Projects focus on brain tumor biology, early cancer detection in TP53 mutation carriers, and data-driven precision oncology platforms. Recent publications emphasize glioma therapy outcomes, meningioma resistance mechanisms, and single-cell multiomics for personalized treatment. His work integrates clinical trials (e.g., INTERLINK-1, CATNON trial) with advanced imaging/radiation toxicity studies and cfDNA analysis. Teaching roles include courses in medical oncology, hemato-oncology, and clinical reasoning.